Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.03
(10.04%)
CNY 14.03
(10.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.17 Billion CNY | -1.89% |
| 2022 | 1.1 Billion CNY | 47.01% |
| 2021 | 753.63 Million CNY | 65.22% |
| 2020 | 456.14 Million CNY | 59.81% |
| 2019 | 285.43 Million CNY | 47.33% |
| 2018 | 193.74 Million CNY | 10.31% |
| 2017 | 175.63 Million CNY | 47.49% |
| 2016 | 119.08 Million CNY | -45.06% |
| 2015 | 216.76 Million CNY | 74.52% |
| 2014 | 124.2 Million CNY | -35.83% |
| 2013 | 193.55 Million CNY | 29.12% |
| 2012 | 149.9 Million CNY | 17.15% |
| 2011 | 127.96 Million CNY | 3.35% |
| 2010 | 123.81 Million CNY | 52.01% |
| 2009 | 81.45 Million CNY | 65.94% |
| 2008 | 49.08 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 236.89 Million CNY | -6.95% |
| 2024 Q3 | 192.42 Million CNY | -18.77% |
| 2024 Q1 | 254.59 Million CNY | 374.96% |
| 2023 Q2 | 365.49 Million CNY | 4.59% |
| 2023 FY | 1.08 Billion CNY | -1.89% |
| 2023 Q3 | 370.9 Million CNY | 1.48% |
| 2023 Q4 | 53.6 Million CNY | -85.55% |
| 2023 Q1 | 349.45 Million CNY | 49.35% |
| 2022 Q1 | 253.54 Million CNY | 23.99% |
| 2022 FY | 1.1 Billion CNY | 47.01% |
| 2022 Q4 | 233.98 Million CNY | -26.44% |
| 2022 Q3 | 318.11 Million CNY | 5.24% |
| 2022 Q2 | 302.26 Million CNY | 19.22% |
| 2021 Q2 | 215.84 Million CNY | 90.35% |
| 2021 FY | 753.63 Million CNY | 65.22% |
| 2021 Q3 | 219.9 Million CNY | 1.88% |
| 2021 Q4 | 204.48 Million CNY | -7.01% |
| 2021 Q1 | 113.39 Million CNY | -30.64% |
| 2020 Q1 | 42.9 Million CNY | -65.98% |
| 2020 Q3 | 130.8 Million CNY | 9.96% |
| 2020 Q4 | 163.48 Million CNY | 24.98% |
| 2020 FY | 456.14 Million CNY | 59.81% |
| 2020 Q2 | 118.96 Million CNY | 177.29% |
| 2019 Q1 | 55.11 Million CNY | -32.84% |
| 2019 FY | 285.43 Million CNY | 47.33% |
| 2019 Q4 | 126.11 Million CNY | 210.69% |
| 2019 Q3 | 40.59 Million CNY | -36.19% |
| 2019 Q2 | 63.61 Million CNY | 15.41% |
| 2018 Q1 | 62.48 Million CNY | 58.14% |
| 2018 FY | 193.74 Million CNY | 10.31% |
| 2018 Q4 | 82.06 Million CNY | 794.07% |
| 2018 Q3 | 9.17 Million CNY | -77.06% |
| 2018 Q2 | 40.01 Million CNY | -35.97% |
| 2017 Q4 | 39.51 Million CNY | -19.07% |
| 2017 Q2 | 41.07 Million CNY | -11.11% |
| 2017 Q1 | 46.21 Million CNY | 120.56% |
| 2017 Q3 | 48.82 Million CNY | 18.86% |
| 2017 FY | 175.63 Million CNY | 47.49% |
| 2016 Q1 | 42.35 Million CNY | 17.53% |
| 2016 FY | 119.08 Million CNY | -45.06% |
| 2016 Q4 | 20.95 Million CNY | -59.77% |
| 2016 Q3 | 52.08 Million CNY | 1312.26% |
| 2016 Q2 | 3.68 Million CNY | -91.29% |
| 2015 Q2 | 74.6 Million CNY | 75.33% |
| 2015 Q1 | 42.55 Million CNY | 35.74% |
| 2015 FY | 216.76 Million CNY | 74.52% |
| 2015 Q4 | 36.03 Million CNY | -43.31% |
| 2015 Q3 | 63.57 Million CNY | -14.79% |
| 2014 Q1 | 33.95 Million CNY | -33.76% |
| 2014 FY | 124.2 Million CNY | -35.83% |
| 2014 Q2 | 28.42 Million CNY | -16.29% |
| 2014 Q4 | 31.34 Million CNY | 2.84% |
| 2014 Q3 | 30.48 Million CNY | 7.25% |
| 2013 Q3 | 36.94 Million CNY | 0.0% |
| 2013 FY | 193.55 Million CNY | 29.12% |
| 2013 Q4 | 51.25 Million CNY | 38.75% |
| 2012 FY | 149.9 Million CNY | 17.15% |
| 2011 FY | 127.96 Million CNY | 3.35% |
| 2010 FY | 123.81 Million CNY | 52.01% |
| 2009 FY | 81.45 Million CNY | 65.94% |
| 2008 FY | 49.08 Million CNY | 0.0% |